Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Thrombosis and Haemostasis

• Publication date

  2007-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH07-04-0285PMID 17938811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

  2006cited by this paper
• Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

  2006cited by this paper
• Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials).

  2006cited by this paper
• Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

  2006cited by this paper
• Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28).

  2006cited by this paper
• One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.

  2005cited by this paper
• Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention.

  2005cited by this paper
• Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

  2004cited by this paper
• A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

  2004cited by this paper
• Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction.

  2004cited by this paper
• A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries

  2004cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Soluble CD 40 Ligand in Acute Coronary Syndromes

  2003cited by this paper
• Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment.

  2003cited by this paper
• Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction.

  2002cited by this paper
• The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty.

  2002cited by this paper
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

  2001cited by this paper
• For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt

  2001cited by this paper
• Inflammatory role of platelets in acute coronary syndromes

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

  2001cited by this paper
• Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

  2001cited by this paper
• Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen.

  2001cited by this paper
• [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban].

  2001cited by this paper
• Recognition of the importance of embolization in atherosclerotic vascular disease.

  2000cited by this paper
• Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

  2000cited by this paper
• Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy

  2000cited by this paper
• Intracoronary stenting and risk for major adverse cardiac events during the first month.

  1998cited by this paper
• Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.

  1997cited by this paper
• A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

  1996cited by this paper
• Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men

  1991cited by this paper

• The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Atrial Fibrillation and Its Comorbidities

  2025cites this paper
• Platelet-to-albumin ratio is an independent predictor for ventricular aneurysm formation in ST segment elevation myocardial infarction

  2024cites this paper
• Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction

  2024cites this paper
• Platelet count as a prognostic marker for acute respiratory distress syndrome

  2024cites this paper
• Platelet to albumin ratio: A risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.

  2023cites this paper
• Predictive value of combining leucocyte and platelet counts for mortality in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention treatment in Chinese population: a retrospective cohort study

  2023cites this paper
• Platelet-to-Lymphocyte Ratio as an Independent Factor Associated With Atrial Tachyarrhythmia

  2023cites this paper
• The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Long-Term Survival in Patients With Severe Left Ventricular Dysfunction and Implantable Cardioverter Defibrillator

  2023cites this paper
• Unique crosstalk between platelet and leukocyte counts during treatment for acute coronary syndrome: A retrospective observational study

  2022influential citation
• Platelet-hemoglobin ratio predicts amputation in patients with below-knee peripheral arterial disease

  2022cites this paper
• Platelet-to-Hemoglobin Ratio Is an Important Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction

  2022cites this paper
• The age-specific prognostic impact of the platelet-to-lymphocyte ratio on long-term outcome after acute coronary syndrome

  2021cites this paper
• The Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR), Monocyte to Lymphocyte Ratio (MLR) and Platelet to Lymphocyte Ratio (PLR) on Long-Term Survival in Off-Pump Coronary Artery Bypass Grafting (OPCAB) Procedures

  2021cites this paper
• Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study

  2021cites this paper
• Platelet-lymphocyte ratio as a new predictor of in-hospital mortality in cardiac intensive care unit patients

  2021cites this paper
• Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure

  2021cites this paper
• The relationship between inflammation and hematological parameters in chronic kidney disease

  2021cites this paper
• Mean Platelet Volume/Platelet Count Ratio and Culprit Plaque Morphologies: An Optical Coherence Tomography Study in Patients with ST Segment Elevation Myocardial Infarction

  2021cites this paper
• Evaluation of Platelet-to-Lymphocyte Ratio in Predicting Early and Long Term Outcomes Following Acute Coronary Syndrome

  2020cites this paper
• Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention

  2020cites this paper
• The short-term prognostic value of serum platelet to hemoglobin in patients with type A acute aortic dissection

  2020cites this paper
• Platelet-to-hemoglobin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: A retrospective cohort study

  2020cites this paper
• Comparative effects of atorvastatin 80 mg versus rosuvastatin 40 mg on the neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and monocyte to HDL-cholesterol ratio in patients with acute myocardial infarction

  2019cites this paper
• Prognostic value of fibrinogen-to-albumin ratio in predicting 1-year clinical progression in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention

  2019cites this paper
• Association between Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios and Coronary Artery Calcification Score among Asymptomatic Patients: Data from a Cross-Sectional Study

  2019cites this paper
• The Association of Platelet Count , Lymphocyte Count and Platelet / Lymphocyte Ratio with the Severity of Coronary Artery Disease

  2019cites this paper
• THE DIFFERENCE BETWEEN ABSOLUTE NEUTROPHILS,NEUTROPHIL/ LYMPHOCYTE RATIO AND PLATELET/LYMPHOCYTE RATIO IN NORMAL, NSTEMI, STEMI PATIENTS

  2019cites this paper
• Association between baseline platelet count and severe adverse outcomes following percutaneous coronary intervention

  2018cites this paper
• Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty.

  2018cites this paper
• Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.

  2018cites this paper
• Usefulness of platelet to lymphocyte ratio for predicting recurrence of atrial fibrillation after direct current cardioversion

  2018cites this paper
• Systemic effects of controlled exposure to diesel exhaust: a meta-analysis from randomized controlled trials

  2017cites this paper
• Relationship between platelet to lymphocyte ratio and coronary angiography timing in patients with NSTEMI

  2017cites this paper
• Age modulates the relationship between platelet-to-lymphocyte ratio and coronary artery disease.

  2017cites this paper
• Association of Platelet to lymphocyte ratio with non-culprit atherosclerotic plaque vulnerability in patients with acute coronary syndrome: an optical coherence tomography study

  2017cites this paper
• Comparison of prognostic significance of mean platelet volume/platelet count with GRACE for long-term prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.

  2017cites this paper
• The Association between Platelet/Lymphocyte Ratio and Coronary Artery Disease Severity in Asymptomatic Low Ejection Fraction Patients

  2016cites this paper
• The relation of platelet–lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction

  2016cites this paper
• Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease

  2016cites this paper
• Association Between Platelet to Lymphocyte Ratio and Saphenous Vein Graft Disease

  2016cites this paper
• Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention.

  2016cites this paper
• Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome

  2016cites this paper
• Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

  2016influential citation
• The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease

  2016cites this paper
• Relation between unconjugated bilirubin and RDW, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio in Gilbert’s syndrome

  2016cites this paper
• Usefulness of admission hematologic parameters as diagnostic tools in acute pulmonary embolism

  2015cites this paper
• The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation

  2015cites this paper
• Platelet–lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome

  2015cites this paper
• The association of the platelet-to-lymphocyte ratio with mitral annular calcification

  2015cites this paper
• Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent

  2015cites this paper
• Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis

  2015cites this paper
• Relationship between the presence of left atrial thrombus in patients with mitral stenosis and platelet-to-lymphocyte ratio

  2015cites this paper
• Mediterranean diet and low-grade subclinical inflammation: the Moli-sani study.

  2015cites this paper
• The Relation of Platelet–Lymphocyte Ratio and Coronary Collateral Circulation in Patients With Stable Angina Pectoris and Chronic Total Occlusion

  2015cites this paper
• Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes.

  2014cites this paper
• ST Yükselmeli Miyokard İnfarktüslü Hastalarda Stent Trombozunu Öngörmede Trombosit-Lenfosit Oranının Kullanışlılığı

  2014cites this paper
• Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome

  2014cites this paper
• Usefulness of Platelet-Lymphocyte Ratio to Predict Stent Thrombosis in Patients with ST Elevation Myocardial Infarction

  2014cites this paper
• The association between platelet/lymphocyte ratio and coronary artery disease severity

  2014cites this paper
• The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention

  2014cites this paper
• Could elevated platelet-lymphocyte ratio predict left ventricular systolic dysfunction in patients with non-ST elevated acute coronary syndrome?

  2014cites this paper
• Assessment of Platelet to Lymphocyte Ratio to Predict Stent Thrombosis in Patients with ST Elevation Myocardial Infarction

  2013cites this paper
• Clopidogrel "resistance": where are we now?

  2013cites this paper
• Evaluation of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients undergoing major vascular surgery

  2013cites this paper
• Evaluation of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients undergoing major vascular surgery Majör vasküler cerrahi yapilan hastalarda ameliyat öncesi nötrofil-lenfosit orani ve trombosit-lenfosit oraninin değerlendirilmesi

  2013cites this paper
• Baseline platelet count and clinical outcome in acute coronary syndrome.

  2012cites this paper
• Platelet turnover in atherothrombotic disease.

  2012cites this paper
• Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction

  2012cites this paper
• Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study

  2012cites this paper
• Prevalence of thrombocytosis in critically ill patients and its association with symptomatic acute pulmonary embolism

  2012cites this paper
• Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction

  2011cites this paper
• Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.

  2010cites this paper
• Relation of platelet count to bleeding and vascular complications in patients undergoing coronary angiography.

  2010cites this paper
• Safety and Antithrombotic Efficacy of Moderate Platelet Count Reduction by Thrombopoietin Inhibition in Primates

  2010cites this paper
• Understanding the complexity of abciximab-related thrombocytopenia

  2010cites this paper
• A novel method of thrombelastograph analysis aids assessment of antiplatelet therapy in percutaneous coronary intervention

  2010cites this paper
• Characterization of prothrombotic pathways in vivo, and discovery of potential new therapies for pathological blood coagulation

  2009cites this paper
• Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome

  2009cites this paper
• Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting

  2008cites this paper
• Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials

  2008cites this paper